Diabetes
and Fasting
“JUST BLAME IT ON BREAKFAST”
Over
the last few weeks, our class has received a general refresher on diabetes –
its causes, symptoms, and treatments. As we have all learned, diabetes is an
extremely prevalent disease that has an extraordinary impact on many peoples’
lives across the globe. It seems that the current trend of diabetes prevalence
is on an upward slope, with more and more people being diagnosed with the
disease with each passing year. Costing our healthcare system billions of
dollars and imposing broad lifestyle restrictions on patients with the disease,
diabetes is certainly a malady that could use a remedy. While we have learned
about some current drugs and treatment regimens aimed at managing diabetes, the
world is still seeking the next revolutionary discovery which hopefully has a
higher efficacy. However, the research surrounding diabetes treatment can lead
down two paths: treatments for the existing diabetic condition, and precautionary
measures aimed at preventing the disease altogether. In this paper, I wish to
bore all of you greatly by expanding on a topic that I believe will be a
prominent preventative measure for diabetes in the future: intermittent fasting.
The discussion about fasting and
diabetes begins a few years ago, when I was a fresh high school graduate who
decided it may finally be time to lose weight and get into shape. My family
grew up without a lot of money, and so I developed poor eating habits at a
young age. I was all too used to junk food, fast food, and eating whenever I
felt like it. I eventually reached a certain point of self-loathing where I
decided that I should show more respect to myself and my body, and I started to
research weight loss and weight lifting. I began eating more nutritious foods,
restricting my calories, and curling as many dumbbells as I could find. I
became very interested in researching these topics and trying to figure out
what behaviors and protocols had real-world results: after all, something you
read in one study will likely be directly contradicted in another study. However,
one topic that I have learned about, practiced myself, and have seen supported
time and time again is the topic of intermittent fasting.
So, what exactly is fasting? In the
simplest terms, fasting can be defined as the complete avoidance of caloric
intake. By avoiding calories for a certain length of time, the body enters a
fasted state where insulin levels are at their lowest, catecholamine levels
(e.g. adrenaline) are high, and endogenous energy sources (fat stores,
glycogen, etc.) are utilized instead of exogenous sources (the cheeseburger
sitting in your small intestine). Now, fasting is certainly not a healthy
continuous long-term practice. If you cease eating altogether, your body will
begin to break itself down for energy and you will eventually die. Intermittent
fasting aims to avoid this negative side-effect by taking advantage of the
fasted state for a specified duration, and then exiting the fasted state well
before your body begins to break itself down. While some intermittent fasters
choose to consume meals only every other day, a method known as alternate-day
fasting, many people choose to continue eating daily while still entering a
fasted state. In practice, this is accomplished by permitting yourself a
limited daily eating window in which calories are consumed, with the majority
of a 24-hour period having no caloric intake. In simpler terms: don’t eat
breakfast. In fact, many practitioners of intermittent fasting only consume
their meals between noon and 8PM, resulting in 16 hours of caloric avoidance
every day.
While this may seem like a small
behavioral change, fasting can cause a multitude of beneficial effects across a
wide range of domains. For example, fasting is one of the only dietary
practices shown to increase mammalian lifespan (Carlson and Hoelzel 1946; Goodrick et
al. 1982; Heilbronn et al. 2005; Mair
and Dillin 2008; Uno et al. 2013; Weindruch
and Walford 1982; Wolf 2006). In regards to exercise and fat loss, fasting
primes the body for lipolysis and increased energy expenditure via higher
levels of catecholamines and low levels of insulin. However, fasting also causes a plethora of
metabolic and physiological changes that would be valuable for the diabetic
patient. An example of such changes would be an increase in insulin
sensitivity, lower levels of inflammation, and lower blood pressure (Andersson et al. 1988; Anson et al.
2003; Mattson and Wan 2005). While these effects may be more targeted for
patients with Type 2 diabetes (e.g. increased insulin sensitivity), fasting
also has beneficial effects on patients with Type 1 diabetes (Mojaddidi et al. 2006; Reiter et al.
2007) though insulin dosages may need to be adjusted to the new meal timing.
Overall, fasting seems to be a safe practice for diabetic patients and the
aforementioned effects are certainly advantageous to a maladjusted metabolic
response (AlAlwan and Al Banyan 2010;
Hui et al. 2010; Sheikh and Wallia
2007).
It’s not hard to see that the
physiological changes produced by fasting could serve as part of a treatment
plan for an existing diabetic condition. However, I believe that fasting would
also be an important practice in preventing the onset of diabetes altogether.
As previously mentioned, fasting basically primes the body for the next visit
to the gym: low insulin levels prevent the body from entering storage mode.
High catecholamine levels increase the magnitude of the fight or flight
response while simultaneously increasing blood flow to adipose tissue. Exiting
the fasted state on a daily basis means your body will maintain its leptin
levels and not enter a weight loss plateau. Exercise is one of the best precautionary
measures to prevent the onset of diabetes, and fasting acts synergistically
with exercise. However, I don’t think acting as an exercise primer is the only
reason why fasting may act as a preventative treatment for diabetes.
A
few weeks ago, our class discussed how the inhibition of GSK-3 produced
beneficial effects in regards to pancreatic beta cell proliferation and
survival. This prompted me to research whether the metabolic pathways affected
by fasting also affect GSK-3 expression or not. Through some brief research, I
found that while GSK-3 has a broad
variety of inhibitors, a very notable and effective inhibitor is Protein Kinase
A (Fang et al. 2000). PKA phosphorylates both the alpha and beta forms
of GSK-3, resulting in the total deactivation of the molecule. It turns out that both glucagon and
epinephrine stimulate the production of PKA (Johnson 2003). Glucagon
release can be increased by the activation of both alpha-1 and alpha-2
adrenoceptors, something that normally occurs during periods of fasting via
raised catecholamine levels (Layden et al. 2010; Skoglund et al. 1987). Furthermore, PKA
activity is dependent on cAMP; without cAMP, PKA cannot perform its function (Fang et
al. 2000). Conveniently enough,
both fasting and increased glucagon expression result in higher plasma
concentrations of cAMP (Chang et al. 2002; Liljenquist et al. 1974; Mjoos et al. 1977). By consolidating all of this information, we can
see the following physiological changes (theoretically) brought about by
fasting:
Now,
the inhibition of GSK-3 via entering a fasted state is a purely hypothetical
pathway that I inferred from the meta-analysis of the previously mentioned
studies. I could not find any studies that explicitly stated an increase in
GSK-3 inhibition from a fasted state, but I wouldn’t be surprised if this is
actually the case. As previously mentioned, fasting produces a broad multitude
of beneficial effects without many known causes or mechanisms of action.
Perhaps the inhibition of GSK-3 is just one of the causes of fasting’s
beneficial effects, but more research would be needed before this could be
relied upon.
Piecing this all together, I believe
that intermittent fasting has great potential in both preventing and treating diabetes.
For current patients, intermittent fasting produces metabolic changes that may
help curb the disease with the help of exercise and other drugs. As a
preventative measure, fasting allows exercise to more easily exhibit its
beneficial effects which are known to prevent the onset of diabetes. More
importantly, however, the increased catecholamine levels seen during the fasted
state may allow you to pump out one or two more curls on your last set.
References
AlAlwan I and Al Banyan A. 2010. Effects of Ramadan fasting on
children with Type 1 diabetes. International Journal of Diabetes Mellitus 2:127-129.
Andersson B, Wallin G, Hedner T,
Ahlberg AC, Andersson OK. 1988.
Acute effects of short-term fasting on blood pressure, circulating
noradrenaline and efferent sympathetic nerve activity. Acta Med Scand. 223:485-490.
Anson RM, Guo Z, de Cabo R, Iyun T,
Rios M, Hagepanos A, Ingram DK, Lane MA, and Mattson MP. 2003. Intermittent fasting dissociates beneficial effects of
dietary restriction on glucose metabolism and neuronal resistance to injury
from calorie intake. PNAS 100:6216-6220.
Carlson AJ and Hoelzel F. 1946. Apparent Prolongation of the Life
Span of Rats by Intermittent Fasting. J. Nutr 31:363-375.
Chang LL, Kau MM, Wun WS, Ho LT, and
Wang PS. 2002. Effects of fasting on
corticosterone production by zona fasciculata-reticularis cells in
ovariectomized rats. Journal of Investigative Medicine 50:86-94.
Fang X, Yu SX, Lu Y, Bast RC Jr,
Woodgett JR, and Mills GB. 2000.
Phosphorylation and inactivation of glycogen synthase kinase 3 by protein
kinase A. Proc Natl Acad Sci USA 97:11960-11965.
Goodrick CL, Ingram DK, Reynolds MA,
Freeman JR, Cider NL. 1982. Effects
of Intermittent Feeding Upon Growth and Life Span in Rats. Gerontology 28:233-241.
Heilbronn LK, Smith SR, Martin CK,
Anton SD, and Ravussin E. 2005.
Alternate-day fasting in nonobese subjects: effects on body weight, body
composition, and energy metabolism. Am J Clin Nutr 81:69-73.
Hui E, Bravis V, Hassanein M, Hanif
W, Malik R, Chowdhury TA, Suliman M, and Devendra D. 2010. Management of people with diabetes wanting to fast during
Ramadan. British Medical Journal 340:1407-1411.
Johnson L. 2003. Essential Medical Physiology. Academic Press. Page 643 – ISBN
978-0-12-387584-6.
Layden BT, Durai V and Lowe WL. 2010. G-Protein-Coupled Receptors,
Pancreatic Islets, and Diabetes. Nature Education 3:13.
Liljenquist JE, Bomboy JD, Lewis SB,
Sinclair-Smith BC, Felts PW, Lacy WW, Crofford OB, and Liddle GW. 1974. Effect of glucagon on net
splanchnic cyclic AMP production in normal and diabetic men. The Journal of
Clinical Investigation 53:198-204.
Mair W and Dillin A. 2008. Aging and Survival: The Genetics
of Life Span Extension by Dietary Restriction. Annual Review of Biochemistry
77:727-754.
Mattson MP and Wan R. 2005. Beneficial effects of
intermittent fasting and caloric restriction on the cardiovascular and
cerebrovascular systems. The Journal of Nutritional Biochemistry 16:129-137.
Mjoos OD, Vik-Mo H, Henden T, and
Wang H. 1977. Increased plasma
cyclic AMP concentrations in fasting man. Scandinavian Journal of Clinical and
Laboratory Investigation 37:439-442.
Mojaddidi M, Hassanein M, and Malik
RA. 2006. Ramadan and diabetes:
evidence-based guidelines. Prescriber 17:38-43.
Reiter J, Wexler ID, Shehadeh N, Tzur
A, and Zangen D. 2007. Type 1
diabetes and prolonged fasting. Diabetic Medicine 24:436-439.
Sheikh A and Wallia S. 2007. Ramadan fasting and diabetes.
British Medical Journal 335:613-614.
Skoglund G, Lundquist I, and Ahren B.
1987. Alpha 1- and alpha
2-adrenoceptor activation increases plasma glucagon levels in the mouse.
European Journal of Pharmacology 143:83-88.
Uno M, Honjoh S, Matsuda M, Hoshikawa
H, Hishimoto S, Yamamoto T, Ebisuya M, Yamamoto T, Matsumoto K, and Nishida E. 2013. A Fasting-Responsive Signaling
Pathway that Extends Life Span in C. elegans. Cell Reports 3:79-91.
Weindruch R and Walford RL. 1982. Dietary restriction in mice
beginning at 1 year of age: effect on life-span and spontaneous cancer
incidence. Science 215:1415-1418.
Wolf G. 2006. Calorie Restriction Increases Life Span: A Molecular
Mechanism. Nutrition Reviews 64:89-92.
so many references i am very smart www.mensa.org/mike
I like how you obviously feel strongly about this solution and how you applied things learned in class to this discussion. It would be interesting to see the actual results that you were suggesting with the possible increase of PKA levels as well. If this turned out to be significant however, I think it would be extremely difficult to change America's culture to adopt this solution...
ReplyDeleteI enjoyed your take on the issues with diabetes. I think you are hitting the root of the problem. It's not so much that diabetes is becoming more contagious, it has a lot to do with our diet and lifestyle. However I do agree with the comment Bryan makes, this lifestyle would be an incredibly difficult habit to change. I think maybe it could be a combined effort of americans changing their lifestyle as well as fast food and companies that promote incredibly unhealthy products to take some responsibility for their products as well. Similar to cigarette companies.
ReplyDelete